Tuesday, 22 September 2015
Nonprofit Buys Back Rights To Tuberculosis Drug, Lowers Cost
But, a pharmaceutical CEO at another company is defending why he bought the rights to an AIDS drug and then upped the price from $13.50 to $750 overnight. Also, the makers of Tylenol push to fend off tough new restrictions on acetaminophen.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment